Erratum in: Cost per responder for upadacitinib vs abatacept in patients with moderate-to-severe Rheumatoid Arthritis in Italy

Detalles Bibliográficos
Autores principales: Caporali, Roberto, Ravasio, Roberto, Raimondo, Paola, Salaffi, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2022
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768591/
https://www.ncbi.nlm.nih.gov/pubmed/36628313
http://dx.doi.org/10.33393/grhta.2022.2383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768591/
https://www.ncbi.nlm.nih.gov/pubmed/36628313
http://dx.doi.org/10.33393/grhta.2022.2383

Ejemplares similares